Apogee Therapeutics, Inc (NASDAQ:APGE) Signals Accelerated Value Capture After Strategic Funding And Acquisition Agreement
Apogee enters a near-term phase of liquidity-driven optionality with pipeline milestones and corporate transactions sharpening the outlook. Strong balance-sheet metrics contrast with negative operating earnings, creating a valuation gap WMDST identifies as under-valued.









